Follow the Iperionx Limited stock price and the full insider trade history of the company, a listed issuer based in Australia. Shares trade on AU AU, under the supervision of ASX. Operating in the Chemicals sector, Iperionx Limited has logged 4 insider filings. Market capitalisation: €1.4bn. The latest transaction was reported on 23 June 2026 (Cease Substantial Holding). Among the most active insiders: Unknown Substantial Holder. The full history is free.
Analysts rate Iperionx Limited Strong Buy (bullish), based on 2 analysts. Average price target: A$8.85.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
Iperionx Limited is a company focused on the chemistry and materials sector. It is listed on the Australian Securities Exchange (ASX).